DMD Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

Drug Metabolism and Disposition Fast Forward
First published on April 25, 2006; DOI: 10.1124/dmd.106.009613

0090-9556/06/3407-1237-1246$20.00
DMD 34:1237-1246, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Erratum
Right arrow An erratum has been published
Right arrow All Versions of this Article:
dmd.106.009613v1
34/7/1237    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukherjee, B.
Right arrow Articles by Weinshilboum, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukherjee, B.
Right arrow Articles by Weinshilboum, R. M.

GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICSFormula

Baidehi Mukherjee, Oreste E. Salavaggione, Linda L. Pelleymounter, Irene Moon, Bruce W. Eckloff, Daniel J. Schaid, Eric D. Wieben, and Richard M. Weinshilboum

Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics (B.M., O.E.S., L.L.P., I.M., R.M.W.), Department of Biochemistry and Molecular Biology (B.W.E., E.D.W.), and Department of Health Sciences Research (D.J.S.), Mayo Clinic College of Medicine, Rochester, Minnesota

Glutathione S-transferase omega 1 and omega 2 (GSTO1 and GSTO2) catalyze monomethyl arsenate reduction, the rate-limiting reaction in arsenic biotransformation. As a step toward pharmacogenomic studies of these phase II enzymes, we resequenced human GSTO1 and GSTO2 using DNA samples from four ethnic groups. We identified 31 and 66 polymorphisms in GSTO1 and GSTO2, respectively, with four nonsynonymous-coding single nucleotide polymorphisms (cSNPs) in each gene. There were striking variations among ethnic groups in polymorphism frequencies and types. Expression constructs were created for all eight nonsynonymous cSNPs, as well as a deletion of codon 155 in GSTO1, and those constructs were used to transfect COS-1 cells. Quantitative Western blot analysis, after correction for transfection efficiency, showed a reduction in protein level of greater than 50% for the GSTO1 Tyr32 variant allozyme compared with wild type (WT), whereas levels for the Asp140, Lys208, Val236, and codon 155 deletion variant constructs were similar to that of the WT. For GSTO2, the Tyr130 and Ile158 variant allozymes showed 50 and 84% reductions in levels of expression, respectively, compared with WT, whereas the Ile41 and Asp142 allozymes displayed levels similar to that of WT GSTO2. Rabbit reticulocyte lysate degradation studies showed that the GSTO1 Tyr32 and the GSTO2 Tyr130, Ile158, and Asp142/Ile158 variant allozymes were degraded more rapidly than were their respective WT allozymes. These observations raise the possibility of functionally significant pharmacogenomic variation in the expression and function of GSTO1 and GSTO2.

Address correspondence to: Dr. Richard M. Weinshilboum, Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905. E-mail: weinshilboum.richard{at}mayo.edu




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
L. Wang, S. Kumar, B. L. Fridley, K. R. Kalari, I. Moon, L. L. Pelleymounter, M. A.T. Hildebrandt, A. Batzler, B. W. Eckloff, E. D. Wieben, et al.
Proteasome {beta} Subunit Pharmacogenomics: Gene Resequencing and Functional Genomics
Clin. Cancer Res., June 1, 2008; 14(11): 3503 - 3513.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. A. Leil, C. Endo, A. A. Adjei, G. K. Dy, O. E. Salavaggione, J. R. Reid, M. M. Ames, and A. A. Adjei
Identification and Characterization of Genetic Variation in the Folylpolyglutamate Synthase Gene
Cancer Res., September 15, 2007; 67(18): 8772 - 8782.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.